相关实验视频
Updated: Sep 13, 2026

08:47
Oral Health Assessment by Lay Personnel for Older Adults
Published on: February 2, 2020
1979年至1987年,美国腹死亡人数. 这对老年人来说是一个特殊的问题
J F Lew1, R I Glass, R E Gangarosa
1Viral Gastroenteritis Unit, Centers for Disease Control, Atlanta, GA 30333.
JAMA
|June 26, 1991
概括
腹不成比例地影响美国的老年人,超过一半的死亡发生在74岁以上的人群中. 风险因素包括白人,女性和长期护理,这表明需要有针对性的预防措施.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 老年学是指老年学的学科.
背景情况:
- 全球范围内,腹是幼儿死亡的重要原因之一.
- 关于成年人群中腹死亡的数据有限.
- 了解所有年龄段的腹死亡趋势对于公共卫生干预至关重要.
研究的目的:
- 检查美国所有年龄组的腹死亡趋势.
- 确定与腹死亡率相关的人口和风险因素.
- 为了调查腹死亡的季节性模式.
主要方法:
- 利用来自国家卫生统计中心 (1979-1987) 的国家死亡率数据.
- 包括腹是直接或潜在原因的死亡.
- 分析了不同年龄组的数据,包括老年人,成年人和幼儿.
主要成果:
- 在9年的时间里,28,538人死于腹.
- 大多数腹死亡发生在老年人中 (51%),其次是55-74岁的成年人 (27%) 和幼儿 (11%).
- 老年人死亡的风险因素包括白人,女性和居住在长期护理机构;在老年人和幼儿中观察到明显的冬季高峰.
结论:
- 老年人群,特别是长期护理的老年人群,患腹死亡率的风险很高.
- 需要进一步的研究来探索预防策略,如口服补水疗法和针对高危老年人的疫苗.
- 季节性模式表明一些人群中腹的传染性起源,需要进一步调查.
相关概念视频
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
